Esper Georges Kallás
Esper Georges Kallás
Professor Associado e Livre Docente da Faculdade de Medicina da Universidade de São Paulo
Adresse e-mail validée de
Citée par
Citée par
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men
RM Grant, JR Lama, PL Anderson, V McMahan, AY Liu, L Vargas, ...
New England Journal of Medicine 363 (27), 2587-2599, 2010
Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study
RM Grant, PL Anderson, V McMahan, A Liu, KR Amico, M Mehrotra, ...
The Lancet infectious diseases 14 (9), 820-829, 2014
Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men
PL Anderson, DV Glidden, A Liu, S Buchbinder, JR Lama, JV Guanira, ...
Science translational medicine 4 (151), 151ra125-151ra125, 2012
Cabotegravir for HIV prevention in cisgender men and transgender women
RJ Landovitz, D Donnell, ME Clement, B Hanscom, L Cottle, L Coelho, ...
New England Journal of Medicine 385 (7), 595-608, 2021
Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans
DI Watkins, DR Burton, EG Kallas, JP Moore, WC Koff
Nature medicine 14 (6), 617-621, 2008
Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 …
R Palacios, EG Patiño, R de Oliveira Piorelli, MTRP Conde, AP Batista, ...
Trials 21, 1-3, 2020
International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for …
TC Mast, L Kierstead, SB Gupta, AA Nikas, EG Kallas, V Novitsky, ...
Vaccine 28 (4), 950-957, 2010
Circulating follicular helper–like T cells in systemic lupus erythematosus: association with disease activity
JY Choi, JH Ho, SG Pasoto, V Bunin, ST Kim, S Carrasco, EF Borba, ...
Arthritis & rheumatology 67 (4), 988-999, 2015
No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis
JL Marcus, DV Glidden, KH Mayer, AY Liu, SP Buchbinder, KR Amico, ...
PloS one 8 (12), e81997, 2013
HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial
MB Deutsch, DV Glidden, J Sevelius, J Keatley, V McMahan, J Guanira, ...
The lancet HIV 2 (12), e512-e519, 2015
Upregulation of reactive oxygen species generation and phagocytosis, and increased apoptosis in human neutrophils during severe sepsis and septic shock
PS Martins, EG Kallas, MC Neto, MA Dalboni, S Blecher, R Salomão
Shock 20 (3), 208-212, 2003
Syphilis predicts HIV incidence among men and transgender women who have sex with men in a preexposure prophylaxis trial
MM Solomon, KH Mayer, DV Glidden, AY Liu, VM McMahan, JV Guanira, ...
Clinical Infectious Diseases 59 (7), 1020-1026, 2014
Efficacy and safety of a COVID-19 inactivated vaccine in healthcare professionals in Brazil: the PROFISCOV study
R Palacios, AP Batista, CSN Albuquerque, EG Patiño, JP Santos, ...
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial
AC Medeiros-Ribeiro, NE Aikawa, CGS Saad, EFN Yuki, T Pedrosa, ...
Nature medicine 27 (10), 1744-1751, 2021
Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study
B Grinsztejn, B Hoagland, RI Moreira, EG Kallas, JV Madruga, S Goulart, ...
The lancet HIV 5 (3), e136-e145, 2018
Prior Dengue virus exposure shapes T cell immunity to Zika virus in humans
A Grifoni, J Pham, J Sidney, PH O'Rourke, S Paul, B Peters, SR Martini, ...
Journal of virology 91 (24), 10.1128/jvi. 01469-17, 2017
Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
MM Solomon, JR Lama, DV Glidden, K Mulligan, V McMahan, AY Liu, ...
Aids 28 (6), 851-859, 2014
Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal
FA Legrand, DF Nixon, CP Loo, E Ono, JM Chapman, M Miyamoto, ...
PloS one 1 (1), e102, 2006
Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository
R Kassanjee, CD Pilcher, SM Keating, SN Facente, E McKinney, MA Price, ...
Aids 28 (16), 2439-2449, 2014
QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans
TG Evans, MJ McElrath, T Matthews, D Montefiori, K Weinhold, M Wolff, ...
Vaccine 19 (15-16), 2080-2091, 2001
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20